ArticleCancer medicine2024

Clinical efficacy and safety of first-line nilotinib or imatinib therapy in patients with chronic myeloid leukemia-Nationwide real life data.

Petra Belohlavkova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.